Back to Results
First PageMeta Content



t 4 Report* Metabolomics in Toxicology and Preclinical Research Tzutzuy Ramirez 1§, Mardas Daneshian 2§, Hennicke Kamp 1, Frederic Y. Bois 3, Malcolm R. Clench 4, Muireann Coen 5, Beth Donley 6, Steven M. Fischer 7, Dr
Add to Reading List

Open Document

File Size: 969,16 KB

Share Result on Facebook

City

Utrecht / Konstanz / Santa Clara / Ispra / Baltimore / Madison / Ludwigshafen / Saarbruecken / Athens / Berlin / Zeist / Frankfurt / London / Berkshire / /

Company

Bayer Pharma AG / metanomics GmbH / Sanofi-Aventis Deutschland GmbH / Syngenta / Agilent Technologies / Stephens / Agilent Life Sciences Group / BASF SE / Bruker / Stemina Biomarker Discovery Inc. / National Exposure Research Laboratory / /

Continent

Europe / /

Country

Netherlands / France / United Kingdom / Germany / Italy / United States / /

Event

FDA Phase / /

Facility

Saarland University / Imperial College / University of Konstanz / Biomedical Research Centre / Sheffield Hallam University / Technological University of Compiegne / International Research Centre / Federal Institute / Johns Hopkins University / /

IndustryTerm

silico tools / sample processing / cell culture media / chemical risk assessment / adverse chemical effects / chemical insult / potential applications / chemical toxicity / pharmaceuticals / reference systems / metabolomics technologies / analytical technologies / throughput test systems / energy requirements / in vitro systems / deep sequencing technologies / chemical communication / metabolic networks / chemicals / test systems / clinical applications / biotechnology / chemical hazards / applicable solutions / metabolite network / offer solutions / intricate metabolic network / data processing bias / biological systems / secretome technologies / chemical screening applications / technology providers / information-rich technologies / chemical-induced changes / unknown chemicals / test chemical / model systems / estimation tools / cell systems / omics technologies / active systems / chemical / chemical structure / metabolomics protocols / toxicological applications / /

MedicalCondition

inflammatory and non-parenchymal cells / cell injury / sterility / injury / cholestasis / MS / necrosis / disease / human relevant diseases / inflammation / /

MedicalTreatment

drug therapies / /

Organization

Department of Scientific Services / Joint Research Centre / Institute for Health & Consumer Protection / European Commission / European Union / International Research Centre / Doerenkamp-Zbinden Foundation / Sheffield Hallam University / Sheffield / Royallieu Research Center / Federal Institute for Risk Assessment / National Institute of Health / Saarland University / Technological University of Compiegne / Center for Alternatives / Imperial College London / Johns Hopkins University / Department of Product / Bloomberg School of Public Health / University of Konstanz / Biomedical Research Centre / US National Research Council / Environmental Protection Agency / /

Person

Claude Guillou / Helena T. Hogberg / Gerhard Krennrich / Drew R. Ekman / Silvia Wagner / Steven M. Fischer / Erik Peter / Nigel Skinner / Thomas Hartung / Beth Donley / Marcel Leist / Harald Jungnickel / Andreas Luch / Joachim Heuer / Frederic Y. Bois / Malcolm R. Clench / Mark Seymour / Hector C. Keun / Lena Smirnova / Eric Fabian / /

Position

chair / /

Product

PoT / /

Technology

proteomics / omics technologies / deep sequencing technologies / apoptosis / drug discovery / metabolomics technologies / Metabolomics / toxicogenomics / bioinformatics / secretome technologies / biotechnology / metabolic networks / transcriptomics / metabolomics protocols / /

URL

http /

SocialTag